mTOR
mTOR inhibitors are compounds that inhibit the activity of Mammalian Target of Rapamycin (mTOR), a central regulator of cell growth, proliferation, metabolism, and survival. The mTOR pathway is frequently altered in cancer and other diseases, making mTOR a critical target for therapeutic intervention. Inhibitors of mTOR are widely used in research related to cancer, aging, and metabolic disorders. At CymitQuimica, we offer a variety of mTOR inhibitors to support your research in signal transduction, oncology, and therapeutic development.
Read more
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | AZD 3147 REF: TM-T36200CAS: 1101810-02-9 | 98.34% | 94.00 €~1,045.00 € | Mon 13 Jan 25 |
AZD 3147
CAS:1101810-02-9
AZD 3147 inhibits mTORC1 (40.7 nM), mTORC2 (5.75 nM), and PI3Kα/β/δ/γ (912/5495/9333/6310 nM IC50s).
Formula:
C24H31N5O4S2
Purity:
98.34%
Color and Shape:
Solid
Molecular weight:
517.66
Ref: TM-T36200
| 1mg | 94.00 € | ||
| 1ml | 266.00 € | ||
| 5mg | 206.00 € | ||
| 10mg | 329.00 € | ||
| 25mg | 566.00 € | ||
| 50mg | 756.00 € | ||
| 100mg | 1,045.00 € |
Estimated delivery in United States, on Monday 13 Jan 2025
